BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 28033277)

  • 1. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
    Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
    BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Video-assisted thoracic lobectomy
    Detillon DDEMA; Aarts MJ; De Jaeger K; Van Eijck CHJ; Veen EJ
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
    Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
    Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
    Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
    Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
    Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
    Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
    Miyazaki T; Yamazaki T; Nakamura D; Sato S; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Surg Today; 2017 Dec; 47(12):1476-1483. PubMed ID: 28447170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
    Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer.
    Li H; Shen Y; Wu Y; Cai S; Zhu Y; Chen S; Chen X; Chen Q
    J Surg Res; 2019 Nov; 243():346-353. PubMed ID: 31277011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function.
    Tomita N; Okuda K; Kita N; Niwa M; Hashimoto S; Murai T; Ishikura S; Nakanishi R; Shibamoto Y
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):634-641. PubMed ID: 35098662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
    Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.